Clarivate Plc, a global leader in providing trusted information and insights to accelerate the pace of innovation, recently shared its list of Highly Cited Researchers™ 2020. This annual list identifies researchers who demonstrated significant influence in…
Mass General Brigham Innovation Fund Licensing Agreement with Biogen to Focus on Developing Treatment for Inherited Retinal Degeneration Due to Mutations in the PRPF31 Gene July, 2, 2020: (BOSTON) – Massachusetts Eye and Ear, a member…
Medical research can be an electrifying experience as novel ideas are turned into life-altering solutions. On the other hand, research can also be incredibly frustrating, especially when your work has reached a desired result, yet, you’re not certain…
Mass General Brigham Innovation is maximizing the healthcare system’s growth strategy by investing in bold, transformative innovations and increasing commercialization opportunities. Watch an update from a recent system-wide townhall featuring Innovation team members Chris Coburn, Chief…
Six disruptive scientific advancements from Mass General Brigham have been awarded Innovation Discovery Grants (IDG) in the 2020 round of awards, as the highly competitive IDG program exceeds $3.5 million in grants since inception. Each of…
The COVID-19 virus has taken over life as we know it, creating a novel environment for science in which collaboration is key and extraordinary speed is expected without sacrificing accuracy. Funded through Operation Warp Speed, the…
Recent Posts by Category
Cardiovascular diseases remain the leading cause of death worldwide and rising expense, making this area ripe for AI-enabled innovations. This AI Update includes discussions…
Six disruptive scientific advancements from Mass General Brigham have been awarded Innovation Discovery Grants (IDG) in the 2020 round of awards, as the highly…
The Partners Innovation Fellows Program provides up-and-coming faculty/staff physicians and investigators from Partners with an opportunity to work with an industry partner on an…
The COVID-19 virus has taken over life as we know it, creating a novel environment for science in which collaboration is key and extraordinary…
To read the full interview, click here.
Diseases related to thrombus and fibrosis are a key contributor to strokes, heart attacks, organ failure and death and result in billions of dollars…
The gap between the development of AI and its use and integration in the clinic is closing, as technology, sophisticated algorithms, data sets, and…
Mass General Brigham Innovation is maximizing the healthcare system’s growth strategy by investing in bold, transformative innovations and increasing commercialization opportunities. Watch an update…
How do these new funds enhance the Partners Innovation Fund? These funds extend the capabilities we built with PIF. TIF will allow us to…
At the 2020 World Medical Innovation Forum, Joerg Moeller, MD, PhD reflected on how Bayer is weathering the organizational challenges posed by the COVID-19…
Innovation Discovery Grants Awarded to Mass General Brigham Scientific Advancements Designed to Help Patients, Healthcare Delivery
Six disruptive scientific advancements from Mass General Brigham have been awarded Innovation Discovery Grants (IDG) in the 2020 round of awards, as the highly competitive IDG program exceeds $3.5 million in grants since inception. Each of the five potential patient health and healthcare delivery break-throughs for 2020 will receive $100,000…
Read MoreThe 2020 Disruptive Dozen
TOP 12 DISRUPTIVE HEALTHCARE TECHNOLOGIES Mapping spread of infectious diseases and reducing health disparities top list Mass General Brigham announced its selections for the sixth annual “Disruptive Dozen,” the 12 emerging clinical and artificial intelligence technologies with the greatest potential to impact health care in the next year. The Disruptive…
Read MorePartners HealthCare Creates New Investment Funds to Accelerate Innovation in Medicine
$80M Investment to Speed Discovery from Lab to Patient, Fuel Life Sciences Economy Partners HealthCare has announced the creation of two new investment funds aimed at addressing the lack of translational funding in pre-clinical life sciences, Artificial Intelligence (AI) and digital technology development. The funds will support ventures that develop…
Read MorePrinted from https://innovationblog.partners.org/blog · Published 25 Jan 2021
© Mass General Brigham Incorporated. All rights reserved.